The innate immune system is crucial for the early detection of invading pathogens and functions by recognizing specific PAMPs via germ line-encoded PRRs^[@R8]^. Downstream signaling following PRR and ligand binding leads to elicitation of innate immune responses and subsequent modulation of the adaptive responses thereby orchestrating a complex network of host defenses^[@R8]^. Cyclic di-nucleotides (CDNs), which are either produced by invading bacterial pathogens (such as, c-di-AMP and c-di-GMP) or produced endogenously in response to foreign DNA (cyclic GMP-AMP, cGAMP) represent one such category of small molecules that, during infection, act as triggers for innate immune responses leading to induction of Type I interferons (IFN-α/β)^[@R2],[@R6],[@R9]^. CDNs triggers Type I IFN induction through TLR-independent pathways^[@R9]^ that include direct interaction with endoplasmic reticulum (ER) membrane protein STING or the cytosolic receptor DDX41, which complexes with STING followed by signal activation via phosphorylation of Tank binding kinase 1 (TBK1) and Interferon Regulatory Factor 3 (IRF3)^[@R5],[@R10]^. While the potency of cytosolic signaling induced by CDNs and dsDNA appears comparable^[@R9]^, the sensors for these molecules may be unique with minimal redundancy^[@R10]--[@R11]^. Of the several putative mammalian cytosolic DNA sensors that signal through STING^[@R12]^, cyclic GMP-AMP synthase (cGAS) has recently been shown to be essential for DNA-mediated immune responses irrespective of cell type and nucleic acid sequence^[@R11]^. On detection of foreign nucleic acid, cGAS synthesizes a non-canonical CDN, cGAMP, which subsequently binds to STING leading to induction of Type I IFNs via the same signaling axis as that used by bacterial CDNs^[@R11]^. The production of a host-generated CDN in response to foreign nucleic acid may account for the apparent overlap of the responses to the structurally distinct ligands.

Like several pathogenic bacteria, the *M. tuberculosis* genome encodes a di-adenylate cyclase enzyme (*disA* or *dacA, Rv3586, MT3692*) which synthesizes c-di-AMP from ATP or ADP^[@R4]^,. Orthologues of *disA* exist in all mycobacterial genomes with the exception of *M. leprae*. However, the role of c-di-AMP in *M. tuberculosis* physiology and mechanism of its interaction with the host immune system is poorly understood^[@R13]--[@R14]^. Evidence from other intracellular bacterial infections strongly suggests that both microbial DNA and CDNs stimulate the secretion of Type I IFNs^[@R2],[@R15]^. However, the existing model for *M. tuberculosis* infection hypothesizes that extracellular mycobacterial DNA is the only ligand for CSP activation within macrophages, which leads to increased autophagy and bacterial clearance in an Esx-1 secretion system dependent manner excluding any role of bacterial CDNs in CSP activation^[@R16]--[@R17]^. Here we report that c-di-AMP, not cytosolic DNA alone, is a critical ligand for CSP activation leading to induction of Type I IFNs and autophagy during *M. tuberculosis* infection.

To confirm that *M. tuberculosis* produces and secretes c-di-AMP, we first detected and quantified bacterial c-di-AMP production in 7H9 broth culture and found considerable levels in both the intracellular and extracellular compartments by employing highly sensitive LC-MS/MS MRM methods ([Supplementary Fig. 1a, b](#SD1){ref-type="supplementary-material"}). We also observed that intracellular c-di-AMP levels increase during late-log and stationary phases of growth of *M. tuberculosis* compared to early log phase growth ([Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}). Further *M. tuberculosis*-produced c-di-AMP was also detected in the infected macrophage cytosol ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}). Next, we constructed a recombinant *M. tuberculosis* strain over-expressing its endogenous di-adenylate cyclase gene, *disA* (Mtb-OE) ([Supplementary Fig. 2a, b](#SD1){ref-type="supplementary-material"}). Analysis of the transcriptome by mRNA sequencing revealed a 95-fold over-expression of *disA* in the Mtb-OE strain compared to the *M. tuberculosis* CDC1551 wild type (WT) control strain ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}) with a resultant increase in the production of c-di-AMP by \~20 fold ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}). The absence of any c-di-AMP in the mutant bacterial strain ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}) with a transposon insertion disrupting the di-adenylate cyclase domain of *disA* (JHU-3586, <http://webhost.nts.jhu.edu/target/>) confirms that c-di-AMP is produced by a single di-adenylate cyclase in *M. tuberculosis*. Complementation of the mutant bacteria with its endogenous *disA* gene and native promoter reconstituted c-di-AMP production (Mtb-COMP) ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}).

To investigate whether perturbations of c-di-AMP levels in *M. tuberculosis* influence host Type I IFN responses, we infected J774.1 mouse macrophage cells with *M. tuberculosis* strains expressing different c-di-AMP levels, and measured IFN-β levels by ELISA at 24 hours post-infection. As shown in [Fig. 1a, b](#F1){ref-type="fig"}, infection with the Mtb-*disA*-KO strain resulted in a significant reduction in IFN-β induction by J774.1 cells compared to infection with the Mtb-CDC1551. Conversely, infection with the Mtb-OE strain resulted in an enhanced induction of IFN-β by both resting and activated J774.1 cells. Notably, Mtb-OE infected cells also secreted significantly higher levels of TNF-α compared to the Mtb-WT infected cells, whereas Mtb-*disA*-KO infected cells produced lower TNF-α levels compared to other groups ([Fig. 1c, d](#F1){ref-type="fig"}). Moreover, the patterns of IRF pathway activation in THP1-human monocyte cells ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}) and IFN-β responses in mouse primary bone marrow derived macrophages (BMDM) and dendritic cells (BMDC) ([Fig. 1e, f](#F1){ref-type="fig"}) were comparable further confirming our hypothesis. However, we noticed that mouse BMDCs are a comparatively better IFN-β producer than BMDMs in response to *M. tuberculosis* infection, which has also been reported by others^[@R18]^. Induction of IFN-β was further confirmed by real time RT-PCR of the BMDC cells infected with various *M. tuberculosis* strains ([Fig. 1g](#F1){ref-type="fig"}). We also observed induction of significantly higher levels of pro-inflammatory cytokines including IL-1α, IL-6 and TNF-α by both BMDMs and BMDCs following infection with the c-di-AMP over-expressing *M. tuberculosis* strain ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). These observations suggest that perturbation of c-di-AMP levels in *M. tuberculosis* not only influences the CSP mediated Type I IFN response but also plays a critical role in modulating the pro-inflammatory cytokine signature of the infected cells.

Taking into account the ambiguous role of the Type I IFN response in host control of TB, we monitored the growth patterns of these *M. tuberculosis* strains in resting and IFN-γ/LPS activated J774.1 cells. While all *M. tuberculosis* WT and recombinant strains exhibited identical growth rates in 7H9 broth culture ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}), the Mtb-OE strain exhibited significantly diminished intracellular growth compared with the other *M. tuberculosis* strains ([Fig. 1h, i](#F1){ref-type="fig"}). We did not notice any growth attenuation of the Mtb-*disA*-KO strain. These observations reveal that over-expression of c-di-AMP by *M. tuberculosis* results in significant attenuation of the intracellular growth of the Mtb-OE strain.

In light of reports indicating that CDNs are potent autophagy inducers^[@R16],[@R19]^, we investigated whether enhanced macrophage autophagy might account for the attenuation of the c-di-AMP over-expressing *M. tuberculosis* strain by examining the auto-phagosome membrane specific marker LC3 in *M. tuberculosis* infected J774.1 cells. Fluorescence confocal imaging demonstrated a considerably higher percentage of cells (\~15%) exhibiting LC3 puncta formation in the case of Mtb-OE infection compared to Mtb-CDC1551 (\~10%) and Mtb-*disA*-KO infections (\~6%) ([Fig. 2a, b](#F2){ref-type="fig"}). In addition, Western blot analysis of endogenous LC3 revealed an increase in conversion of LC3-I to LC3-II in the Mtb-OE infected cells, indicating hyper-activation of autophagy ([Fig. 2c](#F2){ref-type="fig"}). We also observed a considerably higher percentage of cells exhibiting pTBK1 positivity suggesting activation of IRF pathway^[@R5],[@R10]^ in the Mtb-OE infected J774.1 cells ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). These observations strongly suggest that hyper-induction of autophagy by macrophages may be one of the contributing factors that restricts the intracellular growth of Mtb-OE strain.

Next we examined the virulence and pathogenicity of the *M. tuberculosis* strains in mouse aerosol infection models. Remarkably, compared to WT infection (median time to death \[MTD\] of 150 days), we observed a significant increase in the survival of Mtb-OE infected mice (MTD 321 days). In contrast, the Mtb-*disA*-KO strain which is c-di-AMP deficient showed reduced survival with an MTD of 77 days ([Fig. 3a](#F3){ref-type="fig"}). Concomitantly, the Mtb-OE strain also exhibited growth attenuation as evidenced by significantly reduced lung and spleen bacillary loads ([Fig. 3b, c](#F3){ref-type="fig"}). Gross and histo-pathological findings of mouse lungs and spleens correlated well with the bacterial organ burden observations ([Fig. 3d, e](#F3){ref-type="fig"}). The lungs of Mtb-OE infected-mice showed significantly fewer and smaller tubercle-like lesions compared to other groups. Concordantly, while Mtb-CDC1551, Mtb-*disA*-KO, and Mtb-COMP strain-infected mice exhibited considerable splenomegaly, spleens of the Mtb-OE infected mice appeared normal in size ([Fig. 3d](#F3){ref-type="fig"}). Altogether, these observations clearly demonstrate attenuation of virulence in the c-di-AMP over-expressing *M. tuberculosis* strain.

Next, we compared the mouse serum cytokine levels between these groups at an early stage of disease: 2 weeks post-infection. Consistent with our *in vitro* studies in mouse and human cells, we observed increased IFN-β levels in the serum of Mtb-OE infected mice compared to the Mtb-CDC1551 and Mtb-*disA*-KO group ([Fig. 3f](#F3){ref-type="fig"}). In addition, the Mtb-OE group exhibited significantly higher serum levels of TNF-α ([Fig. 3g](#F3){ref-type="fig"}). Since Type I IFN (IFN-β) is known to counter-regulate Type II IFN (IFN-γ) responses^[@R20]^, we measured IFN-γ levels in the serum of infected mice ([Fig. 3h](#F3){ref-type="fig"}). We observed a strong inverse relationship between IFN-β and IFN-γ in these mice corresponding to the ability of the *M. tuberculosis*-strains to produce c-di-AMP.

Our studies reveal that bacterial c-di-AMP levels are strongly associated with the immunopathological outcome of *M. tuberculosis* infection in mice. Hence, we next examined the host cytosolic sensors that may detect *M. tuberculosis*-derived c-di-AMP starting with helicase DDX41, a cytosolic DNA and CDN receptor that signals via STING^[@R10],[@R21]^. We performed shRNA-mediated knocked down of DDX41 using RAW-Blue™ ISG cells (InvivoGen) that allow colorimetric measurement of the induction of the IRF pathway. Knockdown of DDX41 caused a significant defect in activation of the IRF pathway and reduced IFN-β induction following infection with all the *M. tuberculosis* strains ([Supplementary Fig. 9a, b, c](#SD1){ref-type="supplementary-material"}). We also observed a significantly reduced TNF-α production by the DDX41 knock-down cells ([Supplementary Fig. 9d](#SD1){ref-type="supplementary-material"}). These results suggest that DDX41 is a key pattern recognition receptor for both DNA and c-di-AMP, and that DDX41 regulates the induction of Type I IFNs as well as TNF-α following *M. tuberculosis* infection.

We then investigated the contribution of STING to the c-di-AMP-mediated IFN-β response during *M. tuberculosis* infection. A partial knock-down of STING in human THP1 cells showed considerably lower IFN-β induction than control cells ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). Moreover, all *M. tuberculosis* strains failed to activate the IRF pathway or induce IFN-β in mouse RAW 264.7 macrophage IRF reporter cells lacking STING (STING-KO) ([Fig. 4a, b, c, d](#F4){ref-type="fig"}). However, LPS, which stimulates Type I IFN through STING-independent pathways, induced elevated IFN-β response even in STING-KO cells ([Fig. 4a, b](#F4){ref-type="fig"}). These results confirm that, in addition to its role in bacterial DNA mediated responses, STING is an essential component for c-di-AMP-mediated activation of the IRF pathway during *M. tuberculosis* infection^[@R17]^. Furthermore, infection of macrophages with *M. bovis* bacille Calmette--Guérin (BCG), which is known to lack the Esx-1 secretion system, also showed activation of the IRF pathway at levels 20--60% of those seen following infection with either the Mtb-CDC1551 or the Erdman strain, a WT *M. tuberculosis* strain considered to be highly virulent ([Fig. 4a, b](#F4){ref-type="fig"}). Importantly, the c-di-AMP over-expressing *M. bovis* BCG strain (BCG-OE) produced a significantly higher IRF and IFN-β response than *M. bovis* BCG itself, thus strongly suggesting that bacterial-derived c-di-AMP gains access to the host cell cytosol despite the absence of an Esx-1 secretion system ([Fig. 4a, b](#F4){ref-type="fig"}). These experiments indicate that, while contributory to overall type I IFN response, Esx-1 may not be essential for c-di-AMP-triggered IRF pathway activation. However, further studies with ESX-1 deleted *M. tuberculosis* strains may provide direct evidence for contribution of ESX-1 secretion system in c-di-AMP mediated responses during *M. tuberculosis* infection.

Next we evaluated the role of cGAS in the detection of bacterial c-di-AMP. We infected primary BMDMs ([Fig. 4e](#F4){ref-type="fig"}) and BMDCs ([Fig. 4f](#F4){ref-type="fig"}) from WT and cGAS-KO mice^[@R22]^ with these mycobacterial strains and measured IFN-β protein levels. While loss of cGAS resulted in a considerably reduced IFN-β response compared to cells with intact cGAS (WT), all c-di-AMP overproducing strains continued to show significantly higher induction of IFN-β in cGAS-KO cells compared to their respective WT mycobacterial strains ([Fig. 4e, f](#F4){ref-type="fig"}). Further, both WT and cGAS-KO BMDMs produced comparable levels of IFN-β following stimulation with synthetic c-di-AMP ([Fig. 4g](#F4){ref-type="fig"}). Real time RT-PCR for IFN-b in BMDCs further confirmed these results ([Fig. 4h](#F4){ref-type="fig"}). These experiments show that while c-di-AMP is a key ligand for IFN-β induction irrespective of cGAS, a significant part of the overall IFN-b response during *M. tuberculosis* infection is cGAS dependent and hence is probably due to bacterial DNA.

Our data thus reveal the involvement of c-di-AMP as an *M. tuberculosis* PAMP that triggers host cell IFN-β secretion and autophagy. These observations expand upon earlier studies which suggested that mycobacterial DNA is the exclusive ligand for inducing the Type I IFN response and that the bacterial Esx-1 secretion apparatus is required for CSP activation^[@R17]^. Our findings, which employed multiple bacterial strains (the *M. tuberculosis* CDC1551 and Erdman strains, and *M. bovis* BCG) each modified to overexpress c-di-AMP and a variety of host phagocytic cells including those defective in important mediators of the CSP (STING, DDX41, and cGAS), consistently demonstrated that c-di-AMP, not bacterial DNA alone, is a key mediator of Type I IFN responses. [Supplementary Table 1](#SD1){ref-type="supplementary-material"} lists major differences in our methods compared with those of earlier studies and reveals that strain, host cell, and methodological differences may have allowed the importance of c-di-AMP to have been overlooked in earlier studies.

We considered the possibility that c-di-AMP-mediated changes in other bacterial antigens might affect Type I IFN response through NOD signaling as reported by Pandey *et al.*^[@R23]^. However, a recent study demonstrated that the enhanced Type I IFN response caused by accumulation of c-di-AMP in a c-di-AMP phosphodiesterase mutant of *M. tuberculosis* is independent of NOD signaling^[@R24]^. This report thus further supports our observations and highlights induction of Type I IFN response by c-di-AMP. Moreover, several publications have also demonstrated that NOD signaling is dispensable for IRF activation during *M. tuberculosis* infection^[@R17]^. Thus, we feel that indirect effects of c-di-AMP on other bacterial PAMPs are unlikely to account for the IFN-β responses we observe. Moreover, absence of any difference in the intra-bacterial cAMP level amongst different *M. tuberculosis* strains further ruled out any off target effect of perturbed *disA* expression or c-di-AMP levels on cAMP-a known inducer of TNF-α^[@R25]^.

The enhanced Type I IFN response consequent to over-production of c-di-AMP observed in this study significantly extends correlative observations in several studies with laboratory as well as clinical isolates of pathogenic bacteria^[@R24],[@R26]--[@R27]^. While Type I IFNs are absolutely critical for resistance to viruses, there are conflicting reports as to whether the IFN-α/β response is beneficial or detrimental to the host during tuberculosis^[@R28]--[@R29]^. For example, loss of the IFN-α receptor in knockout mice confers resistance to tuberculosis suggesting that Type I IFN responses are counterproductive in TB^[@R30]^. In contrast, IFNα/β responses have been shown to enhance antigen cross-presentation in DCs and activation of cytolytic CD8 T cells, which are critical for *M. tuberculosis* clearance^[@R31]--[@R32]^, and the Type I IFN response has also been shown to limit lung infectivity of *M. tuberculosis* in animals devoid of Type II IFN^[@R33]^. Importantly, human TB transcriptome analysis of peripheral blood also revealed upregulation of both Type I and Type II IFN gene profiles suggesting overlapping and dynamic roles of both types of IFN in TB pathogenesis^[@R34]^. Beyond induction of Type I IFN, our study also found enhanced induction of several pro-inflammatory cytokines including IL1-α, TNF-α and IL-6 which are believed to play protective roles during *M. tuberculosis* infection^[@R35]^.

Autophagy is increasingly appreciated as a key mechanism by which macrophages kill intracellular *M. tuberculosis*^[@R36]^, and autophagy inducers such as Vitamin D have also been identified as potential candidates for the treatment of HIV-TB co-infection^[@R37]^. Indeed, certain first-line TB drugs, isoniazid (INH) and pyrazinamide (PZA), may act in part by stimulating autophagy^[@R38]^. Mounting evidence also suggests that mycobacterial DNA^[@R17]^, bacterial CDNs such as c-di-AMP^[@R16],[@R19]^, and induction of the Type I IFN^[@R39]^ response itself are inducers of autophagy. Our observation of CDN-activation of IRF signaling and autophagy is consistent with the emerging appreciation of crosstalk between these two pathways.

While altered virulence and antibiotic resistance has been associated with mutation in c-di-AMP cyclase and phosphodiesterase genes of several bacterial pathogens^[@R28]^, modulation of bacterial c-di-AMP levels has yet to be linked to variables in the clinical presentation of human TB. However, differences in the induction of IFN-β by clinical isolates of *M. tuberculosis*^[@R40]^ and the presence of mutations in the adenylate cyclase (Rv3586) as well as phosphodiesterase (Rv2837c) genes in clinical strains of *M. tuberculosis* (<http://www.tbdb.org/>) suggest a potential association of c-di-AMP levels with forms of human TB disease. This study revealing that c-di-AMP produced by *M. tuberculosis* is a PAMP that modulates Type I IFN response during infection may prompt future correlative human studies.

Our findings highlight the importance of c-di-AMP detection in the host's innate resistance to TB and reveal a previously unappreciated mechanism of CSP activation by bacterial CDNs during *M. tuberculosis* infection. The ability of a small molecule, c-di-AMP, to govern the outcome of intracellular infection suggests novel approaches for the treatment and prevention of TB as well as related diseases.
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![Modulation of host cytokine response and intracellular growth of *M. tuberculosis* by c-di-AMP\
(a) Levels of IFN-β in culture media at 24h post-infection from resting and (b) IFN-γ/LPS activated J774.1 cells infected with various Mtb-strains at an MOI of 1:20. (c) Levels of TNF-α in culture media at indicated time points from resting and (d) IFN-γ/LPS activated J774.1 cells infected with various Mtb-strains at an MOI of 1:20. (e) Levels of IFN-β in culture media at 24h post-infection from BMDM and (f) BMDC cells infected with various Mtb-strains at an MOI of 1:10. ELISA Data are mean ± SE of at the least three experiments (n = 3). \*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by One-way ANOVA with Tukey\'s post test. (g) IFN-β mRNA were assessed by qRT-PCR in BMDCs infected with various Mtb-strains at 24h post-infection; data are mean ± SD (n = 3) and representative of two experiments. \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by One-way ANOVA with Tukey\'s post test. (h) Growth kinetics of various Mtb-strains in resting and (i) IFN-γ/LPS activated J774.1 cells. Data are Mean CFUs ± SD at each time point (n = 3) and representative of two experiments. Bar diagrams (right panels in h and i) represent Mean CFUs ± SD at Day 4. \*, p \< 0.05 and \*\*\*, p \< 0.001 by Student\'s t-test (2-tailed).](nihms661220f1){#F1}

![c-di-AMP produced by *M. tuberculosis* induces autophagy in macrophage cells\
(a) Fluorescence confocal images of J774.1 cells, fixed after 6 hr of infection with various *M. tuberculosis* strains and stained with anti-LC3 antibody; Nuclei-Blue (DAPI), LC3b-Green (AF488). Scale bars depicts 20 µm for 40× images and 10 µm for 100× images. (b) Quantitative analysis of LC3 positive J774.1 cells showing puncta formation. Only those cells were considered as positive and included for quantification, which exhibited formation of large LC3 aggregates occupying area \> 1µm, Percentage of LC3-II positive cells were calculated and data are depicted by box plot indicating Mean (+), Median (−) with quartiles (box margins) and ranges (bars) (n = 9). \*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by One-way ANOVA with Tukey\'s post test. (c) Western blot analysis of LC3-I and LC3-II and GAPDH (loading control) of J774.1 cells at 6 hr after infection along with bar diagram depicting densitometric ratios of normalized LC3-II/LC3-I levels. Data are mean ± SD (n = 2) from two experiments.\*, p \< 0.05 by Student\'s t-test (2-tailed).](nihms661220f2){#F2}

![Attenuation of virulence and pathogenicity in c-di-AMP over-producing *M. tuberculosis* strain\
(a) Survival of mice (n = 10) following infection with various Mtb-strains. \*\*\*, p \< 0.001 by Log-rank (Mantel-Cox) test. (b) Growth kinetics of various *M. tuberculosis*-strains in mouse lungs and (c) spleen after aerosol infection. Data are mean ± SE (n = 4). \*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by Two-way ANOVA with Bonferroni post-test. (d) Gross and (e) histo-pathological features of lungs and spleen of mouse infected with various *M. tuberculosis*-strains. Scale bar is 100 µm. (f) Levels of IFN-β, (g) TNF-α and (h) IFN-γ in the serum of mice infected with *M. tuberculosis*-strains possessing varied ability to produce c-di-AMP. Data are mean ± SE (n = 4). \*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by Student\'s t-test (2-tailed).](nihms661220f3){#F3}

![Contribution of STING and cytosolic DNA receptor cGAS to c-di-AMP mediated activation of IFN-β during *M. tuberculosis* infection\
(a, c) IRF pathway activation as measured by luciferase reporter assay and (b, d) IFN-β levels in the 18h post-infection (MOI = 1:5) and post-stimulation culture supernatants of mouse RAW264.7 derived STING ablated \[STING-KO\] and control \[WT\] macrophage IRF reporter cells. (e) IFN-β induction in BMDMs and (f) BMDCs from control \[WT\] and cGAS ablated \[cGAS-KO\] mouse following infection (MOI = 1:10) with various *Mycobacterium* strains. (g) c-di-AMP concentration dependent induction of IFN-β in mouse BMDMs. Data are mean ± SE of at the least three experiments (n = 4 in a, b; n = 3 in c, d, e, f, g).\*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by Student\'s t-test (2-tailed). (h) Levels of *IFN*-β mRNA were determined by *real-time RT*-*PCR* in BMDCs derived from wild type cGAS sufficient \[WT\] and cGAS ablated \[cGAS-KO\] mouse following infection (MOI = 1:10) with various *Mycobacterium* strains. The IFN-β mRNA expression levels were normalized to β-actin expression and are represented relative to those of untreated cells. Data are mean ± SD (n = 3) and is representative of two experiments. \*, p \< 0.05; \*\*, p \< 0.01 and \*\*\*, p \< 0.001 by Student\'s t-test (2-tailed).](nihms661220f4){#F4}
